Suchergebnisse - "Lervat, Cyril"

PubPharm (6)

1

Low-dose ketamine adjuvant treatment for refractory pain in children, adolescents and young adults with cancer : a pilot study

enthalten in: BMJ supportive & palliative care | 2022

von Courade, M. | Bertrand, A. | Guerrini-Rousseau, L. | +10

2

Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050) : a multicentre, open-label, multicohort, phase 1/2 study

enthalten in: The Lancet. Oncology | 2021

von Gaspar, N. | Venkatramani, R. | Hecker-Nolting, S. | +19

CommentIn: Lancet Oncol. 2021 Sep;22(9):1206-1207. - PMID 34416160

3

Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE) : a multicentre, single-arm, phase 2 trial

enthalten in: The Lancet. Oncology | 2020

von Italiano, A. | Mir, O. | Mathoulin-Pelissier, S. | +19

CommentIn: Lancet Oncol. 2020 Mar;21(3):331-332. - PMID 32078814

4

A multicentric randomized phase II clinical trial evaluating high-dose thiotepa as adjuvant treatment to standard chemotherapy in patients with resectable relapsed osteosarcoma

enthalten in: European journal of cancer (Oxford, England : 1990) | 2020

von Marec-Berard, P. | Dalban, C. | Gaspar, N. | +13

5

High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases : Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2019

von Dirksen, U. | Brennan, B. | Le Deley, M. | +40

CommentIn: J Clin Oncol. 2019 Dec 1;37(34):3173-3175. - PMID 31634031

6

Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006) : a randomised, multicentre, open-label, phase 3 trial

enthalten in: The Lancet. Oncology | 2016

von Piperno-Neumann, S. | Le Deley, M. | Rédini, F. | +23

CommentIn: Lancet Oncol. 2016 Aug;17 (8):1022-1023. - PMID 27511145

1
[1]